ANRO
Alto Neuroscience, Inc.
26.50$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | +135.9% | +9.1% | +34.6% | +31.7% | |
| – | +676.7% | +64.0% | +164.0% | +6.3% | |
| – | – | -115.2% | – | -99.2% | |
| – | +7.6% | -35.8% | +341.5% | -98.8% | |
| – | +7.6% | -35.8% | +341.5% | -98.8% | |
| – | – | – | – | – | |
| – | – | -100.0% | – | – | |
| – | +38.2% | +55.6% | +99.2% | -55.7% | |
| – | +4.3% | +51.1% | +152.0% | -90.4% | |
| – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.